BASEL, Switzerland,
Sept. 17 /PRNewswire-FirstCall/ -
Neuro-Biotech Corp. (PINKSHEETS: MRES) (OTCQB: MRES) announces the
nomination of Doctor Claude Poulin
as President and CEO.
Mr Barry Somervail comments on
today's announcement "Following the change of the Company's
direction during the summer of 2010, I stayed on as a member of
board of directors in order to facilitate the transition process,
and now that this process is complete I am pleased to announce the
relinquishment of my position and duties to Dr. Poulin.
Dr. Claude Poulin, 71, a general
practitioner with over 40 years of experience, owns and operates a
Lachute medical clinic where he continues to practice to this day.
Dr. Poulin will bring his medical experience and expertise, as well
as his knowledge of patients to the board. He is also looking
forward to highlighting the value of the various applications of
Neuro-Biotech products within the medical community.
The appointment of Dr. Claude
Poulin became effective upon the filing of the 8k Form with
the relevant authorities.
Forward Looking Statements
This release contains statements that are made pursuant to the
Safe Harbor Provisions of the Private Securities Litigation Act of
1995. Certain statements in this press release may contain words
such as "anticipates," "believes," "could," "expects," "intends,"
"may," "projects," "targets" and other similar language that is
considered forward-looking statements. These forward-looking
statements are subject to certain risks and uncertainties and
persons reading this release are cautioned that such statements are
only predictions, and that the Company's actual future results or
performance may be materially different. The Company disclaims any
intention or obligation to update or revise forward-looking
information, whether as a result of new information, future events,
or otherwise, could cause the company's actual results to differ
materially from those indicated in any forward-looking
statements.
SOURCE Neuro-Biotech Corp.
Copyright . 17 PR Newswire